Associate editor: K.A. Neve
Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors

https://doi.org/10.1016/S0163-7258(03)00051-2Get rights and content

Abstract

For decades, it has been generally proposed that a given receptor always interacts with a particular GTP-binding protein (G-protein) or with multiple G-proteins within one family. However, for several G-protein-coupled receptors (GPCR), it now becomes generally accepted that simultaneous functional coupling with distinct unrelated G-proteins can be observed, leading to the activation of multiple intracellular effectors with distinct efficacies and/or potencies. Multiplicity in G-protein coupling is frequently observed in artificial expression systems where high densities of receptors are obtained, raising the question of whether such complex signalling reveals artefactual promiscuous coupling or is a genuine property of GPCRs. Multiple biochemical and pharmacological evidence in favour of an intrinsic property of GPCRs were obtained in recent studies. Thus, there are now many examples showing that the coupling to multiple signalling pathways is dependent on the agonist used (agonist trafficking of receptor signals). In addition, the different couplings were demonstrated to involve distinct molecular determinants of the receptor and to show distinct desensitisation kinetics. Such multiplicity of signalling at the level of G-protein coupling leads to a further complexity in the functional response to agonist stimulation of one of the most elaborate cellular transmission systems. Indeed, the physiological relevance of such versatility in signalling associated with a single receptor requires the existence of critical mechanisms of dynamic regulation of the expression, the compartmentalisation, and the activity of the signalling partners. This review aims at summarising the different studies that support the concept of multiplicity of G-protein coupling. The physiological and pharmacological relevance of this coupling promiscuity will be discussed.

Introduction

Cell-to-cell communication is one of the principal characteristics of multicellular organisms. This process relies on the existence of a multitude of transmitters that are released from one cell and that trigger the response in others after specific recognition by specialised receptors. In addition to intracellular receptors that frequently function as transcription modulators, a large variety of cell surface receptors have been identified that can be classified in at least three different groups. The first group contains ion channels (ligand-gated ion channels) whose controlled permeability ensures fast generation of cellular responses through altered ionic fluxes. The second group are ligand-activated membrane-bound tyrosine kinases that phosphorylate key proteins frequently involved in the control of cell proliferation and differentiation. Finally, the third group contains the so-called G-protein-coupled receptors (GPCR) that trigger intracellular responses through elaborate signalling that requires the participation of GTP-binding proteins (G-proteins) and multiple membrane-bound and intracellular partners. The principal characteristic of the latter system is its complexity, which results from the intrinsic property of response amplification throughout the signalling cascade and from the diversity of regulatory mechanisms that control the nature, the amplitude, and the duration of the cellular responses.

GPCRs constitute the largest family of cell surface molecules involved in signal transmission. More than 1000 receptors for sensory (odorants, light, etc.) and chemical stimuli (catecholamines, amino acids, peptides, and even ions) have been identified that share some common structural and biochemical properties. Up to 1–5% of the total cell proteins correspond to GPCRs, and together, their genes represent up to 1% of the total genome of mammalians. Hence, they constitute one of the principal targets of drugs used in pharmacology, especially in the CNS. GPCRs are also referred to as seven-transmembrane domain receptors based on their highly conserved backbone structure (Muller, 2000). Thus, all members of this family are constituted of a single peptide containing seven hydrophobic regions of similar length separated by hydrophilic loops of variable sizes. Based on the homology with the visual pigments bacteriorhodopsin and rhodopsin, whose structures have been elucidated by crystallography Henderson et al., 1990, Okada et al., 2000, it is well established that these receptors are characterised by the presence of seven α-helices crossing the plasma membrane, separated by intracellular and extracellular loops (heptahelical receptors). The NH2 terminus is exposed to the extracellular environment and the COOH terminus is intracellular. Despite the conservation of this original structure, sequence homologies between distinct GPCRs are generally restricted to the transmembrane domains of closely related receptor subtypes. It is generally demonstrated that the ligand recognition site involves the extracellular domains of the receptor (both the NH2 terminus and the extracellular loops) and the pocket formed by the assembly of the seven-transmembrane helices. Interaction of the receptor with intracellular signalling partners (G-proteins) involves intracellular domains (both the COOH terminus and the intracellular loops) Gether, 2000, Wess, 1997, Wess, 1998. On the basis of structural and limited sequence similarities, mammalian GPCRs are now generally classified in at least three different groups. Group A (rhodopsin-type receptors) is the largest group and contains many receptors for classical neurotransmitters (biogenic amines and nucleotides), prostaglandins, and a large variety of peptides and neuropeptides. This first group also contains the multitude of receptors for odorants and the well-known visual pigment rhodopsin as well as the cell surface receptors for some viruses. Group B (secretin/glucagon receptors) contains the receptors for distinct hormones and peptides (e.g., calcitonin, glucagon, parathyroid hormone, secretin, vasoactive intestinal polypeptide, and diuretic hormone). Group C (frequently referred to as the metabotropic glutamate receptors group) was described more recently and contains GPCRs for the amino acids glutamate and γ-aminobutyric acid (GABA) and for the Ca2+ ion. For a review, see Wess (1998) as well as the GPCR database http://www.gpcr.org/7tm/ Horn et al., 1998, Horn et al., 2001.

Although emerging studies have revealed the existence of G-protein-independent signallings through some GPCRs Bockaert & Pin, 1999, Hall et al., 1999, Heuss et al., 1999, Hur & Kim, 2002, a common biochemical feature of these receptors is their interaction with G-proteins and the activation of downstream signalling cascades through a well-documented molecular mechanism. The binding of the transmitter or exogenous agonists alters the conformation of critical domains of the seven-transmembrane helix pocket, which in turn causes changes in the conformation of intracellular domains of the receptor. These changes promote the specific association of the receptor with a variety of heterotrimeric G-proteins. These are composed of an α-subunit interacting with a βγ complex. Activation of the receptor promotes the exchange of a molecule of GDP by a molecule of GTP within the active site of the α-subunit. The binding of GTP causes the dissociation of the heterotrimeric complex, and both the GTP-bound α-subunit and the released βγ complex are then able to interact with intracellular or membrane effectors (enzymes or ion channels). The intrinsic GTPase activity of the α-subunit hydrolyses GTP into GDP, restoring its initial inactive conformation as well as its affinity for the βγ complex. For many receptors, the localisation of the molecular determinants of the receptor involved in the coupling and activation of G-proteins has been investigated. With some exceptions, these studies have highlighted the role of membrane-proximal regions of the second and third intracellular loops and of the COOH terminus of the receptor in driving the coupling. However, up to now, no consensus sequences for G-protein selectivity have been clearly identified (for reviews, see Bockaert & Pin, 1999, Gether, 2000, Li et al., 1994, Wess, 1997, Wess, 1998).

The complexity and specificity of GPCR signalling partly relies on the existence of numerous closely related molecular species of the G-protein subunits Downes & Gautam, 1999, Hildebrandt, 1997, Morris & Malbon, 1999. Up to now, at least 23 α-subunits derived from 17 different genes have been identified and are classified into four families (Gαi/o, Gαs, Gαq/11, and Gα12) (see Table 1). Concerning β- and γ-subunits, at least 6 and 12 different molecular species have been described, respectively Gautam et al., 1998, Vanderbeld & Kelly, 2000. As summarised in Table 1, a large variety of intracellular and membrane effectors have been identified for G-proteins, and the list continues to increase (Hamm, 1998). Although all combinations do not necessarily exist in nature, the theoretical number of heterotrimeric G-protein assemblies is particularly large, and this probably contributes to the diversity and selectivity of intracellular signals activated by GPCRs. As indicated in Table 1, in comparison with the variety of receptors and G-proteins, the number of downstream effectors (enzymes and ions channels) is rather limited, and many related G-proteins (e.g., Gi-1, Gi-2, and Gi-3) ensure the coupling with the same intracellular effector (adenylate cyclase). It is also likely that a given receptor has the possibility to interact independently with many G-proteins within the same class (e.g., Albert & Robillard, 2002, Burford et al., 2000, Chalecka-Franaszek et al., 2000, Offermanns et al., 1994, Wise et al., 1999). The nature of the G-protein involved in the coupling is probably critical in modulating the efficacy and the potency of cell signalling. Within one class of G-proteins, the subtype involved in the transduction from the receptor to the effector will depend on the availability of G-proteins in the vicinity of the receptor and thus may differ from one cell to another Milligan, 1996, Neubig, 1994, Ostrom, 2002, Ostrom et al., 2000.

Section snippets

Mechanisms of signalling complexity

For more than a decade, it has been shown that a given neurotransmitter can trigger the generation of several second messengers in a variety of experimental models. The complexity of intracellular response to a single neurotransmitter is the consequence of the diversity in the signal handling at multiple levels of the response elaboration process. Thus, for the majority of transmitters acting at GPCRs, many receptor subtypes have been identified showing distinct G-protein coupling specificities

Biochemical evidence for the multiplicity of G-protein coupling

As indicated under Section 2.2., the selective inhibition of a subset of G-proteins by diverse approaches was found efficient to impair the stimulation of multiple intracellular responses, confirming the possible divergence of signalling downstream of the G-protein coupling level (Fig. 1B and 1C). However, in many other cases, the functional coupling of the receptor with multiple G-proteins of different classes has been demonstrated (Fig. 1D). Such promiscuous coupling of GPCRs was first

Alteration of G-protein coupling specificity in mutated receptors

Mutagenesis studies of GPCRs has been widely used to depict the molecular determinants of the receptor involved in the functional coupling (both physical interaction and activation) to G-proteins. Although clues concerning both the localisation of critical coupling domains and the molecular mechanisms of G-protein activation have been obtained, conserved sequences driving these processes have not been identified (for reviews, see Gether, 2000, Gudermann et al., 1996, Gudermann et al., 1997,

Multiple active state of G-protein-coupled receptors

Major advances in the understanding of the molecular mechanisms responsible for the activation of G-protein by agonist-bound receptor have been obtained using point mutations within the third intracellular loop of β-adrenergic receptors (Kjelsberg et al., 1992). Substitution of a single residue by any other amino acid was found to result in constitutive activation of the intracellular effector, revealing that in the absence of agonist the receptor is constrained in an inactive conformation.

Selective desensitisation of G-protein coupling

It is generally admitted that the control of transmitter release plays a key role in determining the efficacy of intercellular communication. However, more than 30 years ago, it became obvious that an additional modulation of the transmission was achieved by the regulation of the responsiveness of target cells through alteration in the expression and sensitivity of their specific receptors. Receptor regulation occurs through a variety of cellular mechanisms, including rapid receptor

Conclusion

The initial discovery of the basic mechanisms of signal transduction through GPCRs suggested a relatively simple system, whose principal characteristic was the involvement of multiple signalling partners in a “linear cascade” that essentially contributed to the amplification of the response. Thereafter, the identification of a variety of G-proteins activating (or inhibiting) distinct effectors helped to explain the diversity of intracellular signals that could be transduced through these

Acknowledgements

I thank the National Fund for Scientific Research (FNRS, Belgium, Convention FRSM 3.4588.00) and the Belgian Queen Elisabeth Medical Foundation for their financial support. I am a Research Associate of the FNRS (Belgium).

References (270)

  • L. Birnbaumer

    Receptor-to-effector signaling through G proteins: roles for beta gamma dimers as well as alpha subunits

    Cell

    (1992)
  • A.D. Blake et al.

    Differential opioid agonist regulation of the mouse μ opioid receptor

    J Biol Chem

    (1997)
  • J.L. Blank et al.

    Activation of cytosolic phosphoinositide phospholipase C by G-protein βγ subunits

    J Biol Chem

    (1992)
  • C. Blanpain et al.

    Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways

    J Biol Chem

    (2001)
  • J.L. Boyer et al.

    βγ-Subunit activation of G-protein-regulated phospholipase C

    J Biol Chem

    (1992)
  • A.E. Brady et al.

    G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction

    Cell Signal

    (2002)
  • A.R. Burt et al.

    Agonist occupation of an α2A-adrenoreceptor-Gi1α fusion protein results in activation of both receptor-linked and endogenous Gi proteins. Comparisons of their contributions to GTPase activity and signal transduction and analysis of receptor-G protein activation stoichiometry

    J Biol Chem

    (1998)
  • B. Calandra et al.

    Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor

    Eur J Pharmacol

    (1999)
  • J.J. Cali et al.

    Type VIII adenylyl cyclase. A Ca2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain

    J Biol Chem

    (1994)
  • O. Chabre et al.

    Coupling of the α2A-adrenergic receptor to multiple G-proteins. A simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system

    J Biol Chem

    (1994)
  • J.P. Changeux et al.

    Allosteric receptors after 30 years

    Neuron

    (1998)
  • E.J. Choi et al.

    Calcium and muscarinic agonist stimulation of type I adenylylcyclase in whole cells

    J Biol Chem

    (1992)
  • T.T. Chuang et al.

    G protein-coupled receptors: heterologous regulation of homologous desensitization and its implications

    Trends Pharmacol Sci

    (1996)
  • F. Ciruela et al.

    Metabotropic glutamate 1α and adenosine A1 receptors assemble into functionally interacting complexes

    J Biol Chem

    (2001)
  • J.D. Clark et al.

    A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP

    Cell

    (1991)
  • S. Conchon et al.

    The C-terminal third intracellular loop of the rat AT1A angiotensin receptor plays a key role in G protein coupling specificity and transduction of the mitogenic signal

    J Biol Chem

    (1997)
  • Y. Cordeaux et al.

    Agonist regulation of D2 dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype

    J Biol Chem

    (2001)
  • J.M. Dickenson et al.

    Involvement of G-protein βγ subunits in coupling the adenosine A1 receptor to phospholipase C in transfected CHO cells

    Eur J Pharmacol

    (1998)
  • G.B. Downes et al.

    The G protein subunit gene families

    Genomics

    (1999)
  • M.G. Eason et al.

    Identification of a Gs coupling domain in the amino terminus of the third intracellular loop of the α2A-adrenergic receptor. Evidence for distinct structural determinants that confer Gs versus Gi coupling

    J Biol Chem

    (1995)
  • M.G. Eason et al.

    Chimeric mutagenesis of putative G-protein coupling domains of the α2A-adrenergic receptor. Localization of two redundant and fully competent Gi coupling domains

    J Biol Chem

    (1996)
  • M.G. Eason et al.

    Simultaneous coupling of α2-adrenergic receptors to two G-proteins with opposing effects. Subtype-selective coupling of α2C10, α2C4, and α2C2 adrenergic receptors to Gi and Gs

    J Biol Chem

    (1992)
  • T.A. Esbenshade et al.

    Inducible expression of alpha 1B-adrenoceptors in DDT1 MF-2 cells: comparison of receptor density and response

    Eur J Pharmacol

    (1995)
  • A. Fargin et al.

    Dual coupling of the cloned 5-HT1A receptor to both adenylyl cyclase and phospholipase C is mediated via the same Gi protein

    Cell Signal

    (1991)
  • C.C. Felder et al.

    A transfected m1 muscarinic acetylcholine receptor stimulates adenylate cyclase via phosphatidylinositol hydrolysis

    J Biol Chem

    (1989)
  • S. Ferre et al.

    Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells

    J Biol Chem

    (1998)
  • S.K. Fisher

    Homologous and heterologous regulation of receptor-stimulated phosphoinositide hydrolysis

    Eur J Pharmacol

    (1995)
  • M.T. Fox et al.

    Identification of potential activators of proteinase-activated receptor-2

    FEBS Lett

    (1997)
  • A. Francesconi et al.

    Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation

    J Biol Chem

    (1998)
  • C.M. Fraser et al.

    Cloning, sequence analysis, and permanent expression of a human α2-adrenergic receptor in Chinese hamster ovary cells. Evidence for independent pathways of receptor coupling to adenylate cyclase attenuation and activation

    J Biol Chem

    (1989)
  • K. Fukunaga et al.

    Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation

    J Biol Chem

    (2001)
  • P. Gailly et al.

    Evidence for the dual coupling of the rat neurotensin receptor with pertussis toxin-sensitive and insensitive G-proteins

    FEBS Lett

    (2000)
  • J. Garzón et al.

    Myr+-G12α and Goα subunits restore the efficacy of opioids, clonidine and neurotensin giving rise to antinociception in G-protein knock-down mice

    Neuropharmacology

    (1999)
  • N. Gautam et al.

    The G-protein βγ complex

    Cell Signal

    (1998)
  • S.R. George et al.

    Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties

    J Biol Chem

    (2000)
  • R.L. Gilchrist et al.

    The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals

    J Biol Chem

    (1996)
  • A. Gilchrist et al.

    Antagonists of the receptor-G protein interface block Gi-coupled signal transduction

    J Biol Chem

    (1998)
  • A. Gilchrist et al.

    A dominant-negative strategy for studying roles of G proteins in vivo

    J Biol Chem

    (1999)
  • R. Grisshammer et al.

    Functional coupling with Gαq and Gαil protein subunits promotes high-affinity agonist binding to the neurotensin receptor NTS-1 expressed in Escherichia coli

    FEBS Lett

    (2001)
  • J. Gromoll et al.

    Functional and clinical consequences of mutations in the FSH receptor

    Mol Cell Endocrinol

    (1996)
  • Cited by (266)

    • AI-driven GPCR analysis, engineering, and targeting

      2024, Current Opinion in Pharmacology
    View all citing articles on Scopus
    View full text